DYN
Price
$14.70
Change
+$0.71 (+5.08%)
Updated
Jun 6 closing price
Capitalization
1.59B
53 days until earnings call
XNCR
Price
$9.65
Change
+$0.53 (+5.81%)
Updated
Jun 6 closing price
Capitalization
649.08M
52 days until earnings call
Interact to see
Advertisement

DYN vs XNCR

Header iconDYN vs XNCR Comparison
Open Charts DYN vs XNCRBanner chart's image
Dyne Therapeutics
Price$14.70
Change+$0.71 (+5.08%)
Volume$2.67M
Capitalization1.59B
Xencor
Price$9.65
Change+$0.53 (+5.81%)
Volume$526.02K
Capitalization649.08M
DYN vs XNCR Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. XNCR commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and XNCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (DYN: $11.76 vs. XNCR: $7.55)
Brand notoriety: DYN and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 33% vs. XNCR: 59%
Market capitalization -- DYN: $1.59B vs. XNCR: $649.08M
DYN [@Biotechnology] is valued at $1.59B. XNCR’s [@Biotechnology] market capitalization is $649.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а 0.00% price change this week, while XNCR (@Biotechnology) price change was +0.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.59B) has a higher market cap than XNCR($649M). DYN YTD gains are higher at: -50.085 vs. XNCR (-67.145). XNCR has higher annual earnings (EBITDA): -186.17M vs. DYN (-342.21M). DYN has more cash in the bank: 642M vs. XNCR (498M). DYN has less debt than XNCR: DYN (24M) vs XNCR (232M). XNCR has higher revenues than DYN: XNCR (110M) vs DYN (0).
DYNXNCRDYN / XNCR
Capitalization1.59B649M245%
EBITDA-342.21M-186.17M184%
Gain YTD-50.085-67.14575%
P/E RatioN/AN/A-
Revenue0110M-
Total Cash642M498M129%
Total Debt24M232M10%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNXNCR
RSI
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
82%
Bullish Trend 12 days ago
73%
Momentum
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
77%
MACD
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 25 days ago
71%
Declines
ODDS (%)
Bearish Trend 26 days ago
89%
Bearish Trend about 1 month ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 12 days ago
76%
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+0.51%
CRNX - DYN
53%
Loosely correlated
+1.39%
RNA - DYN
51%
Loosely correlated
+1.81%
ERAS - DYN
51%
Loosely correlated
+1.85%
KYMR - DYN
50%
Loosely correlated
+2.35%
XNCR - DYN
50%
Loosely correlated
-2.58%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RCKT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-2.58%
RCKT - XNCR
59%
Loosely correlated
+6.44%
CRNX - XNCR
58%
Loosely correlated
+1.39%
ERAS - XNCR
57%
Loosely correlated
+1.85%
BEAM - XNCR
57%
Loosely correlated
-0.88%
BCYC - XNCR
54%
Loosely correlated
+2.12%
More